- Home
- BNZI vs MRKR Comparison
BNZI vs MRKR Comparison
Compare BNZI & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- MRKR
- Stock Information
- Founded
- BNZI 2016
- MRKR N/A
- Country
- BNZI United States
- MRKR United States
- Employees
- BNZI N/A
- MRKR N/A
- Industry
- BNZI
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- MRKR Health Care
- Exchange
- BNZI Nasdaq
- MRKR Nasdaq
- Market Cap
- BNZI 16.5M
- MRKR 19.1M
- IPO Year
- BNZI N/A
- MRKR N/A
- Fundamental
- Price
- BNZI $0.63
- MRKR $1.63
- Analyst Decision
- BNZI Strong Buy
- MRKR Strong Buy
- Analyst Count
- BNZI 1
- MRKR 3
- Target Price
- BNZI $24.00
- MRKR $13.17
- AVG Volume (30 Days)
- BNZI 4.1M
- MRKR 102.0K
- Earning Date
- BNZI 08-13-2025
- MRKR 08-13-2025
- Dividend Yield
- BNZI N/A
- MRKR N/A
- EPS Growth
- BNZI N/A
- MRKR N/A
- EPS
- BNZI N/A
- MRKR N/A
- Revenue
- BNZI $6,827,490.00
- MRKR $5,696,123.00
- Revenue This Year
- BNZI $570.18
- MRKR N/A
- Revenue Next Year
- BNZI $34.44
- MRKR $11.28
- P/E Ratio
- BNZI N/A
- MRKR N/A
- Revenue Growth
- BNZI 52.95
- MRKR 71.53
- 52 Week Low
- BNZI $0.54
- MRKR $0.95
- 52 Week High
- BNZI $11.20
- MRKR $5.99
- Technical
- Relative Strength Index (RSI)
- BNZI 37.33
- MRKR 59.94
- Support Level
- BNZI $0.54
- MRKR $1.48
- Resistance Level
- BNZI $0.69
- MRKR $1.53
- Average True Range (ATR)
- BNZI 0.09
- MRKR 0.10
- MACD
- BNZI 0.01
- MRKR -0.01
- Stochastic Oscillator
- BNZI 17.62
- MRKR 67.19
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.